Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group
- 309 Downloads
The clinical trials mechanism of standardized treatment and follow-up for cancer patients with similar stages and patterns of disease is the most powerful approach available for evaluating the efficacy of novel therapies, and clinical trial participation should protect against delivery of care variations associated with racial/ethnic identity and/or socioeconomic status. Unfortunately, disparities in clinical trial accrual persist, with African Americans (AA) and Hispanic/Latino Americans (HA) underrepresented in most studies.
We evaluated the accrual patterns for 10 clinical trials conducted by the American College of Surgeons Oncology Group (ACOSOG) 1999–2009, and analyzed results by race/ethnicity as well as by study design.
Eight of 10 protocols were successful in recruiting AA and/or HA participants; three of four randomized trials were successful. Features that were present among all of the successfully recruiting protocols were: (1) studies designed to recruit patients with regional or advanced-stage disease (2 of 2 protocols); and (2) studies that involved some investigational systemic therapy (3 of 3 protocols).
AA and HA cancer patients can be successfully accrued onto randomized clinical trials, but study design affects recruitment patterns. Increased socioeconomic disadvantages observed within minority-ethnicity communities results in barriers to screening and more advanced cancer stage distribution. Improving cancer early detection is critical in the effort to eliminate outcome disparities but existing differences in disease burden results in diminished eligibility for early-stage cancer clinical trials among minority-ethnicity patients.
KeywordsAfrican American African American Cancer Clinical Trial Patient Navigator Clinical Trial Participation
- 2.Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer. 2006;106:188–95.PubMedCrossRefGoogle Scholar
- 3.NIH Revitalization Act. Public Law 103-43, 1993.Google Scholar
- 5.Beswick AD, Rees K, Griebsch I, Taylor FC, Burke M, West RR, et al. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. Health Technol Assess. 2004;8:iii–iv, ix–x, 1–152.Google Scholar
- 22.Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE II, et al. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg. 2005;190:539–42.PubMedCrossRefGoogle Scholar
- 23.U.S. Census Bureau, Population Division, Population Projections Branch. Maintained by Information and Research Services Internet Staff (Population Division). http://www.census.gov/ipc/www/usinterimproj/ (March 18, 2004).
- 24.McKinnon J. The black population in the United States: March 2002. Current Population Reports, Series P20-541. Washington, DC: U.S. Census Bureau; 2003.Google Scholar
- 25.Ramirez RR, de La Cruz GP. The Hispanic population in the United States: March 2002. Current Population Reports, P20-545. Washington, DC: U.S. Census Bureau; 2002.Google Scholar